DSP and neoplasm: Since monocytes are known to express the DSP-0509 target molecule TLR7, it is reasonable to attribute the strength of the anti-tumor activity of the combination with RT to strong DSP-0509-induced activation of monocytes via TLR7 signal upregulation.